Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
KLRS holding history
Kalaris Therapeutics, Inc. in every 13F filed by Gilead Sciences, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −317,789−100.0% | Sold out | Holders |
| Q2 2025 | 317,789 | $848.5K | 0.1% | −405,484−56.1% | Reduced | Holders |
| Q1 2025 | 723,273 | $5.81M | 0.5% | 00.0% | UnchangedConverted for a 1-for-23 split | Holders |
| Q4 2024 | 16,635,286 | $6.99M | 0.5% | – | No prior filing | Holders |